Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected Thai women enrolled in a phase I safety trial.
| Autor: | Haaland RE, Chaowanachan T, Evans-Strickfaden T, van de Wijgert JH, Kilmarx PH, McLean CA, Hart CE |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2012 Dec 15; Vol. 61 (5), pp. e71-3. |
| DOI: | 10.1097/QAI.0b013e318271c8f9 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|